Search

Your search keyword '"Müller-Tidow, Carsten"' showing total 19 results

Search Constraints

Start Over You searched for: Author "Müller-Tidow, Carsten" Remove constraint Author: "Müller-Tidow, Carsten" Topic t cells Remove constraint Topic: t cells
19 results on '"Müller-Tidow, Carsten"'

Search Results

1. GVHD after CAR T-cell therapy post allogeneic hematopoietic cell transplantation — successfully treated by extracorporeal photopheresis.

2. In Vitro Functionality and Endurance of GMP-Compliant Point-of-Care BCMA.CAR-T Cells at Different Timepoints of Cryopreservation.

Catalog

Books, media, physical & digital resources

3. First third-generation CAR T cell application targeting CD19 for the treatment of systemic IgM AL amyloidosis with underlying marginal zone lymphoma.

4. Definition and Characterization of SOX11-Derived T Cell Epitopes towards Immunotherapy of Glioma.

5. High leukemia-free survival after TBI-based conditioning and mycophenolate mofetil-containing immunosuppression in patients allografted for chronic myelomonocytic leukemia: a single-center experience.

6. Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells.

7. IL-10 inducible CD8+ regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cells.

8. DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center.

9. Comments on "Cost of decentralized CAR T cell production in an academic non‐profit setting".

10. HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue Sarcoma.

11. Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas.

12. Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma.

13. Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T Cells.

14. Assessment of CAR T Cell Frequencies in Axicabtagene Ciloleucel and Tisagenlecleucel Patients Using Duplex Quantitative PCR.

15. Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML).

16. The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma.

17. Response to extracorporeal photopheresis therapy of patients with steroid-refractory/-resistant GvHD is associated with up-regulation of Th22 cells and Tfh cells.

18. Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T Cells.

19. The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients.